|
Volumn 102, Issue 17, 2000, Pages 2031-2037
|
TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An Intravenous nPA for Treatment of Infarcting Myocardium Early II trial substudy
|
Author keywords
Coronary disease; Mortality; Myocardial infarction; Prognosis; Risk factors
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALTEPLASE;
ANTIARRHYTHMIC AGENT;
ANTILIPEMIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
FIBRINOLYTIC AGENT;
HEPARIN;
LANOTEPLASE;
ADULT;
AGED;
ARTICLE;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
ELECTROCARDIOGRAM;
FEMALE;
FIBRINOLYTIC THERAPY;
HEART INFARCTION;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTENSION;
ISCHEMIC HEART DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
MULTICENTER STUDY;
PRIORITY JOURNAL;
PROGNOSIS;
RISK ASSESSMENT;
RISK FACTOR;
SCORING SYSTEM;
ST SEGMENT ELEVATION;
TREATMENT OUTCOME;
|
EID: 0034711145
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.CIR.102.17.2031 Document Type: Article |
Times cited : (1293)
|
References (26)
|